Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9363666rdf:typepubmed:Citationlld:pubmed
pubmed-article:9363666lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:9363666lifeskim:mentionsumls-concept:C0022671lld:lifeskim
pubmed-article:9363666lifeskim:mentionsumls-concept:C0002871lld:lifeskim
pubmed-article:9363666pubmed:issue5lld:pubmed
pubmed-article:9363666pubmed:dateCreated1998-1-7lld:pubmed
pubmed-article:9363666pubmed:abstractTextSide-effects of angiotensin converting enzyme (ACE) inhibitors, such as a slight decrease in hematocrit, are increasingly being reported. A 14-year-old renal transplant patient on enalapril therapy developed anemia with reticulocytosis. She was investigated for other causes of anemia and enalapril therapy was ceased. Her hemoglobin level increased and reticulocyte count decreased after cessation of therapy. No other cause of anemia was found. Although anemia in patients receiving ACE inhibitors such as enalapril has previously been reported, this is the first reported patient who developed anemia associated with mild reticulocytosis and macrocytosis.lld:pubmed
pubmed-article:9363666pubmed:languageenglld:pubmed
pubmed-article:9363666pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9363666pubmed:citationSubsetIMlld:pubmed
pubmed-article:9363666pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9363666pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9363666pubmed:statusMEDLINElld:pubmed
pubmed-article:9363666pubmed:monthOctlld:pubmed
pubmed-article:9363666pubmed:issn0374-5600lld:pubmed
pubmed-article:9363666pubmed:authorpubmed-author:SaatçiUUlld:pubmed
pubmed-article:9363666pubmed:authorpubmed-author:OzenSSlld:pubmed
pubmed-article:9363666pubmed:authorpubmed-author:OzbekNNlld:pubmed
pubmed-article:9363666pubmed:issnTypePrintlld:pubmed
pubmed-article:9363666pubmed:volume39lld:pubmed
pubmed-article:9363666pubmed:ownerNLMlld:pubmed
pubmed-article:9363666pubmed:authorsCompleteYlld:pubmed
pubmed-article:9363666pubmed:pagination626-7lld:pubmed
pubmed-article:9363666pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9363666pubmed:meshHeadingpubmed-meshheading:9363666-...lld:pubmed
pubmed-article:9363666pubmed:meshHeadingpubmed-meshheading:9363666-...lld:pubmed
pubmed-article:9363666pubmed:meshHeadingpubmed-meshheading:9363666-...lld:pubmed
pubmed-article:9363666pubmed:meshHeadingpubmed-meshheading:9363666-...lld:pubmed
pubmed-article:9363666pubmed:meshHeadingpubmed-meshheading:9363666-...lld:pubmed
pubmed-article:9363666pubmed:meshHeadingpubmed-meshheading:9363666-...lld:pubmed
pubmed-article:9363666pubmed:meshHeadingpubmed-meshheading:9363666-...lld:pubmed
pubmed-article:9363666pubmed:meshHeadingpubmed-meshheading:9363666-...lld:pubmed
pubmed-article:9363666pubmed:year1997lld:pubmed
pubmed-article:9363666pubmed:articleTitleEnalapril-induced anemia in a renal transplant patient.lld:pubmed
pubmed-article:9363666pubmed:affiliationPediatric Hematology Unit, Hacettepe University Ihsan Do?ramaci Children's Hospital Ankara, Turkey.lld:pubmed
pubmed-article:9363666pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9363666pubmed:publicationTypeCase Reportslld:pubmed